<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02161211</url>
  </required_header>
  <id_info>
    <org_study_id>1404S49427</org_study_id>
    <nct_id>NCT02161211</nct_id>
  </id_info>
  <brief_title>Dismantling the Components and Dosing of CBT for Co-Occurring Disorders</brief_title>
  <acronym>CBT</acronym>
  <official_title>Dismantling the Components and Dosing of CBT for Co-Occurring Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish a brief CBT intervention that can largely, if not
      fully eliminate the deleterious effect of common co-occurring anxiety disorders on alcohol
      use disorder treatment outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relapse Status</measure>
    <time_frame>4 month follow-up</time_frame>
    <description>Relapse status will be assessed using categorical relapse status (yes vs. no) and a continuous measurement of relapse severity (i.e., percent/number days drinking and drinks per drinking day).</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>CBT Decoupling</condition>
  <condition>CBT Anxiety Reduction</condition>
  <condition>CBT Combined</condition>
  <arm_group>
    <arm_group_label>De-coupling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six sessions of CBT for anxiety-alcohol de-coupling</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anxiety Reduction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Six sessions of CBT for anxiety reduction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>De-coupling</intervention_name>
    <description>Six sessions of CBT for anxiety-alcohol de-coupling</description>
    <arm_group_label>De-coupling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Anxiety Reduction</intervention_name>
    <description>Six sessions of CBT for anxiety reduction.</description>
    <arm_group_label>Anxiety Reduction</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Combined</intervention_name>
    <description>Three sessions devoted to anxiety reduction and to anxiety-alcohol de-coupling each.</description>
    <arm_group_label>Combined</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnostic and Statistical Manual IV diagnosis of panic disorder, generalized anxiety
             disorder, and/or social anxiety disorder within the past 30 days;

          -  inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence

          -  alcohol use in the 30 days preceding the study

          -  ability to provide informed consent

          -  minimum of a sixth grade reading level (deemed necessary to complete study materials);

          -  willingness to provide contact information to confirm study follow-up appointments

          -  lives within proximity to the Twin Cities (e.g., within about an hour's drive) for the
             purpose attending follow-up visits

        Exclusion Criteria:

          -  lifetime history of psychosis or mania by history

          -  cognitive or physical impairment that precludes study participation

          -  currently and seriously suicidal (i.e., plan and intent)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matt Kurshner, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amanda S Unruh, B.S</last_name>
    <phone>612-625-7546</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Lodging Plus Program, Fairview Hospital</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55454</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Matt G Kushner, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 9, 2014</study_first_submitted>
  <study_first_submitted_qc>June 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2014</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>alcohol</keyword>
  <keyword>anxiety</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

